A phase 2 study of ARQ 501 in combination with gemcitabine in adult patients with treatment naïve, unresectable pancreatic adenocarcinoma
Khong, H. T., Dreisbach, L., Kindler, H. L., Trent, D. F., Jeziorski, K. G., Bonderenko, I., Popiela, T., Yagovane, D. M., Dombal, G.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article